CoreWeave Lost $740 Million Sparks AI Economy Debate
CoreWeave reported a $740 million quarterly loss as it stacked up a record backlog and a massive Meta deal, underscor...
Ways To Generate Cash Flow For Bills
Learn various ways to generate cash flow for bills. Implement these methods to ensure you meet your financial obligations.
21,614 articles
Goldman’s Future Tech Turned Gains Lead Markets in 2026
As AI-driven growth reshapes tech investing, Goldman’s Future Tech Leaders ETF outperformed the S&P 500 in the first ...
Which Airline Stock Dominated in 2026: Delta or JetBlue?
Delta leads in profitability amid a volatile fuel backdrop, while JetBlue shows resilience with a tighter balance she...
Justin Timberlake Jessica Biel Money Habits for Families
A rare NYC moment offers more than fashion gossip — it highlights how wealthy couples manage money under scrutiny. Th...
U.S. Government Betting Billions: Three Quantum Stock Winners
A bold government push is reshaping quantum tech and investing. Learn which three big stocks are positioned to win, a...
Synchrony's Credit Numbers Improving as Inflation Bites
Inflation is squeezing wallets, but Synchrony’s credit numbers improving narrative suggests the everyday consumer is ...
Trump Made Stock Trades: Tech Giants and Market Moves
A surprising disclosure spotlighted a flurry of activity around big tech stocks. This article breaks down what it cou...
Why QYLD's Yield Quietly Erodes Your Wealth Over Time
As QYLD pays a steady monthly yield, investors may face a hidden wealth drag from capped upside and return-of-capital...
Cybersecurity Showdown: CrowdStrike Acquisition Push
CrowdStrike accelerates an acquisition push as Palo Alto Networks doubles down on platform strategy. Both leaders rep...
Bath & Body Works Earnings Outlook for BBWI Investors
Investors are watching Bath & Body Works (BBWI) as it navigates growth, margins, and store optimization. This guide b...
Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status